Avantor将临床服务业务出售给Audax私人股,售价为650万澳元。 Avantor sells clinical services business to Audax Private Equity for $650M.
Avantor公司以约6.5亿美元将临床服务业务出售给Audax私人股份公司。 Avantor, Inc. has sold its clinical services business to Audax Private Equity for about $650 million. 这一交易将产生约5亿美元的税后现金,并将资本化租赁减少约5 000万美元。 This transaction is set to generate approximately $500 million in after-tax cash and reduce capitalized leases by around $50 million. 公司计划将收益用于偿还债务,并专注于实验室和生产部门的增长, 提高其财务稳定性和降低利息支出. Avantor plans to use the proceeds to pay down debt and focus on growth in its lab and production sectors, enhancing its financial stability and reducing interest expenses. 新实体将重新命名为 " 共振临床解决方案 " 。 The new entity will be rebranded as Resonant Clinical Solutions.